tradingkey.logo
tradingkey.logo
Suchen

Nuwellis Inc

NUWE
Zur Watchlist hinzufügen
3.150USD
+0.010+0.32%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
5.31MMarktkapitalisierung
2.31KGV TTM

mehr Informationen über Nuwellis Inc Unternehmen

Nuwellis, Inc. is a commercial-stage medical technology company. The Company is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.

Nuwellis Inc Informationen

BörsenkürzelNUWE
Name des UnternehmensNuwellis Inc
IPO-datumFeb 16, 2012
CEOErb (John L)
Anzahl der mitarbeiter38
WertpapierartOrdinary Share
GeschäftsjahresendeFeb 16
Addresse12988 Valley View Rd
StadtEDEN PRAIRIE
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl55344
Telefon19523454200
Websitehttps://www.nuwellis.com/
BörsenkürzelNUWE
IPO-datumFeb 16, 2012
CEOErb (John L)

Führungskräfte von Nuwellis Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Gregory D. (Greg) Waller
Mr. Gregory D. (Greg) Waller
Independent Director
Independent Director
12.00
--
Dr. Archelle (Feldshon) Georgiou, M.D.
Dr. Archelle (Feldshon) Georgiou, M.D.
Independent Director
Independent Director
12.00
--
Erb (John L)
Erb (John L)
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer, Interim Principal Financial Officer and Interim Principal Accounting Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer, Interim Principal Financial Officer and Interim Principal Accounting Officer
--
-100.00%
Dr. Maria Rosa Costanzo, M.D.
Dr. Maria Rosa Costanzo, M.D.
Independent Director
Independent Director
--
--
Mr. Neil P. Ayotte, Esq.
Mr. Neil P. Ayotte, Esq.
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
--
--
Mr. Michael (Mike) Mccormick
Mr. Michael (Mike) Mccormick
Lead Independent Director
Lead Independent Director
--
--
Mr. David Alan (Dave) Mcdonald
Mr. David Alan (Dave) Mcdonald
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Gregory D. (Greg) Waller
Mr. Gregory D. (Greg) Waller
Independent Director
Independent Director
12.00
--
Dr. Archelle (Feldshon) Georgiou, M.D.
Dr. Archelle (Feldshon) Georgiou, M.D.
Independent Director
Independent Director
12.00
--
Erb (John L)
Erb (John L)
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer, Interim Principal Financial Officer and Interim Principal Accounting Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer, Interim Principal Financial Officer and Interim Principal Accounting Officer
--
-100.00%
Dr. Maria Rosa Costanzo, M.D.
Dr. Maria Rosa Costanzo, M.D.
Independent Director
Independent Director
--
--
Mr. Neil P. Ayotte, Esq.
Mr. Neil P. Ayotte, Esq.
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
--
--
Mr. Michael (Mike) Mccormick
Mr. Michael (Mike) Mccormick
Lead Independent Director
Lead Independent Director
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Nuwellis Inc?

Die fünf größten Anteilseigner von Nuwellis Inc sind: Mr. Gregory D. (Greg) Waller

Wie viele Institutionen halten Anteile an Nuwellis Inc (NUWE)?

Mit Stand vom 2026Q1 halten 20 Institutionen Anteile an Nuwellis Inc, mit einem Gesamtmarktwert von etwa 135.71K, was 6.78% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um 58953.00 gestiegen.